- Home
- RNG vs VERA Comparison
RNG vs VERA Comparison
Compare RNG & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNG
- VERA
- Stock Information
- Founded
- RNG 1999
- VERA 2016
- Country
- RNG United States
- VERA United States
- Employees
- RNG N/A
- VERA N/A
- Industry
- RNG EDP Services
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- RNG Technology
- VERA Health Care
- Exchange
- RNG Nasdaq
- VERA Nasdaq
- Market Cap
- RNG 2.3B
- VERA 2.0B
- IPO Year
- RNG 2013
- VERA 2021
- Fundamental
- Price
- RNG $27.67
- VERA $23.82
- Analyst Decision
- RNG Buy
- VERA Buy
- Analyst Count
- RNG 15
- VERA 8
- Target Price
- RNG $34.00
- VERA $64.63
- AVG Volume (30 Days)
- RNG 1.4M
- VERA 1.4M
- Earning Date
- RNG 07-31-2025
- VERA 08-07-2025
- Dividend Yield
- RNG N/A
- VERA N/A
- EPS Growth
- RNG N/A
- VERA N/A
- EPS
- RNG N/A
- VERA N/A
- Revenue
- RNG $2,428,240,000.00
- VERA N/A
- Revenue This Year
- RNG $5.82
- VERA N/A
- Revenue Next Year
- RNG $5.51
- VERA N/A
- P/E Ratio
- RNG N/A
- VERA N/A
- Revenue Growth
- RNG 7.78
- VERA N/A
- 52 Week Low
- RNG $20.59
- VERA $18.53
- 52 Week High
- RNG $42.19
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- RNG 48.08
- VERA 52.93
- Support Level
- RNG $29.41
- VERA $22.57
- Resistance Level
- RNG $30.22
- VERA $24.58
- Average True Range (ATR)
- RNG 0.85
- VERA 1.22
- MACD
- RNG -0.03
- VERA 0.14
- Stochastic Oscillator
- RNG 35.15
- VERA 69.80
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.